Dr. Oz Warns About Shifting from Alcohol to High-Dose Hemp and CBD Products

Dr. Mehmet Oz, current head of CMS, is sounding a bit of a warning bell even as he moves to expand federal access to cannabinoids. While Oz has historically been a vocal supporter of the plant’s therapeutic benefits—especially for seniors looking for alternatives to narcotics—he recently noted that "consequences" are coming as more folks ditch booze for bud. Specifically, he’s pointing at potential health risks from high-dose hemp and CBD products.

Despite the cautious rhetoric, the big news is that Oz is pushing forward with a pilot program to get CBD covered under Medicare as early as this April. This follows a broader executive order to wrap up the federal rescheduling of marijuana to Schedule III. For regular tokers and the industry at large, this is a major win for accessibility. While the "consequences" talk might feel like typical political posturing, seeing a major federal agency move toward insurance coverage for cannabinoids is a massive step in legitimizing our culture and making wellness more affordable for everyone.